Related Experiment Videos
Desmopressin-induced dog ciliary artery relaxation
1Department of Pharmacology, Shiga University of Medical Sciences, Seta, Ohtsu, Japan.
European Journal of Pharmacology
|May 26, 1998
Summary
Desmopressin, a vasopressin V2 receptor agonist, relaxes dog ciliary arteries by stimulating nitric oxide (NO) synthesis in the endothelium. Vasopressin V1 receptors also play a role in desmopressin
Area of Science:
- Pharmacology
- Ophthalmology
- Cardiovascular Research
Background:
- The posterior ciliary arteries supply blood to the eye's ciliary body.
- Vasopressin receptors (V1 and V2) are present in vascular tissues.
- The role of desmopressin in ciliary artery function is not well understood.
Purpose of the Study:
- To investigate the effects of desmopressin on isolated dog posterior ciliary arteries.
- To elucidate the mechanisms underlying desmopressin-induced vasodilation or constriction.
- To determine the involvement of nitric oxide and vasopressin receptor subtypes.
Main Methods:
- Isolated dog posterior ciliary arteries were contracted with prostaglandin F2alpha.
- Desmopressin's effects were assessed with and without endothelium.
- Nitric oxide synthase inhibition (NG-nitro-L-arginine) and L-arginine supplementation were used.
- A selective vasopressin V1 receptor antagonist (SR49059) was employed.
Main Results:
- Desmopressin induced concentration-dependent relaxation in intact arteries, reversed to contraction upon endothelium removal.
- Relaxation was blocked by NG-nitro-L-arginine and restored by L-arginine, indicating nitric oxide mediation.
- SR49059 suppressed desmopressin-induced relaxation and inhibited contractions in endothelium-denuded arteries.
- Desmopressin was significantly less potent than arginine vasopressin.
Conclusions:
- Desmopressin relaxes dog ciliary arteries through endothelium-derived nitric oxide synthesis.
- Both vasopressin V1 and V2 receptors appear to be involved in desmopressin's vascular effects.
- These findings suggest a potential role for desmopressin in modulating ocular blood flow.